Tirzepatide injection is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist.
Weight loss from baseline to after 40 treatment weeks revealed that Tirzepatide (5mg, 10mg, 15mg) offered at least 30%, 60%, and up to 95% greater weight loss, respectively vs. Semaglutide 1mg.
Tirzepatide
Tirzepatide offers at least
30% greater weight-loss
respective of Semaglutide
Tirzepatide offers at least
30% greater weight-loss
respective of Semaglutide
Schedule a complimentary consultation with one of our intake specialists
below to see if you qualify for
Tirzepatide treatments.
Call us:
(623) 343-4242
Email us:
Find us:
Hours:
MON - FRI: 8 a.m. - 5 p.m
SAT: 8 a.m. - 1 p.m.